Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06941740Not ApplicableEnrolling By Invitation

Effects of Reactive Hypoglycaemia on Cognition in Earlier or Later Chronotypes

Role: collaborator

NCT06916039Not ApplicableEnrolling By Invitation

Effects of Breakfast Glycaemic Index on Cognition in Earlier or Later Chronotypes.

Role: collaborator

NCT06679088Enrolling By Invitation

GlyCoBrain Observational Study

Role: lead

NCT04302922Completed

Association Between the Individual Chronotype and Body Composition in German Students - The ChroNu Study

Role: lead

NCT04994327Not ApplicableCompleted

Bread Replacement - Facing the Challenge to Improve Its Quality for Better Metabolic Health

Role: collaborator

NCT04298645Not ApplicableCompleted

Nutrition Trial on the Glycaemic Response to High GI Meals Consumed at Morning vs. Evening-The ChroNu Study

Role: lead

All 6 trials loaded